Contract win could prove to be a turnaround for still-controversial CVS-Caremark merger; will medication adherence programs make a difference?
This round of PBM competition goes to CVS Caremark, which announced in late May that it had won the mail-order (and ancillary) business for the Blue Cross and Blue Shield Government-Wide Service Benefit Plan, also known as the Federal Employee Program (FEP), representing some five million covered lives. CVS Caremark already has had the retail pharmacy business from FEP. On the news, CVS Caremark’s stock rose 3.5% in mid-day trading, representing its highest price since July 2008, and Medco’s stock dropped 9%, according to the Wall Street Journal. The CVS Caremark announcement stated that the contract win was “based on the best overall value,” which implies some significant discounting of service fees.
There have been a number of disputes and disappointments involving CVS Caremark since its 2007 merger, creating a $99-billion/yr retailing behemoth, mostly involving Caremark trying to steer PBM clients toward its retail pharmacies. Less-than-stellar financial results have made analysts call for the merger to be unwound. Now, some financial analysts are saying that the model might prove itself for the longer term.
Branded pharmaceuticals, with some notable exceptions (specialty drugs with exclusive distribution agreements) are mostly indifferent to which PBMs handle them, although all PBMs compete to get the best price from manufacturers. But PBMs and retail pharmacy are competing intensely to manage adherence programs, which could prove to be a differentiator over time.
Trending Data & Response Plans in the Cleanroom Setting
April 30th 2025Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.
ABM’s Digital Solution for Good Manufacturing Practices
April 30th 2025Learn how our digital GMP solution ensures compliance with high regulatory standards, and offers faster, more accurate data access. By utilizing a mobile app for data collection and a management dashboard for task visibility and validation, it goes beyond traditional paper methods to meet growing industry needs.